1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Non-Dasatinib(Sprycel) arm: new trials by email Literature Review of Non-Dasatinib(Sprycel) arm trials Research Report on Non-Dasatinib(Sprycel) arm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea Dasatinib(Sprycel) arm, Non-Dasatinib(Sprycel) arm - Acute Lymphoblastic Leukemia, Pediatric | Phase 2 | Recruiting | Hyoung Jin Kang | 74 | 2024-10-20 | 2026-07-29 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hyoung Jin Kang (1)
South Korea (1)